2025-12-03 - Analysis Report
Okay, here's a comprehensive analysis of Air Products and Chemicals Inc. (APD) based on the data you provided.

**1) Return Rate Comparison and Alpha/Beta Analysis**

*   **Company Overview:** Air Products and Chemicals Inc. is a global industrial gases company providing atmospheric, process and specialty gases, equipment, and services.
*   **Cumulative Return:** APD: -4.29%, VOO: 100.36%
*   **Divergence:** APD significantly underperformed the S&P 500 (VOO), with a divergence of -105.3.  The relative divergence is 5.0, indicating it is near the minimum divergence observed in the past.

**Alpha, Beta and Financial Metric Analysis:**

*   **Alpha:** The alpha is negative for several periods, particularly in recent years (2015-2017, 2018-2020, 2019-2021, 2021-2025, 2022-2025, and 2023-2025), suggesting underperformance relative to the market on a risk-adjusted basis. The recent years (2021-2025, 2022-2025, 2023-2025) show very negative alpha values.
*   **Beta:** The Beta values are mostly below 1 until 2023-2025, increasing to 2.3, indicating that the stock has become more volatile than the S&P 500 in the most recent period.
*   **CAGR:** The compound annual growth rate (CAGR) has been negative in recent periods (-27.0%, -39.0%, and -61.0%), indicating poor investment returns.
*   **MDD:** The maximum drawdown (MDD) is consistently high, indicating significant potential losses from peak to trough.
*   **Capitalization:** The market capitalization (Cap) is in the 57.5 to 68.6 Billion range during the analysis period.

**Analysis:**
The provided data indicates that APD has significantly underperformed the S&P 500. The negative alpha values suggest that the stock has not been able to generate excess returns relative to the market.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 258.41
*   **Last Market Data:** Price: 258.415, Previous Close: 260.86, Change: -0.94
*   **Simple Moving Averages (SMA):**
    *   5-day SMA: 258.786
    *   20-day SMA: 254.9007
    *   60-day SMA: 264.1483

**Analysis:**
The stock price is slightly below its 5-day SMA, above its 20-day SMA, and below its 60-day SMA. This suggests that the stock is in a slightly downward trend in the very short term (5 days), but has bounced back and is still underperforming in the short- to mid-term (60 days). The negative change from the previous close confirms this recent downward movement.

**3) RSI, PPO, and Divergence Analysis**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 49.97 (Neutral - neither overbought nor oversold)
*   **PPO:** 0.4101
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (4 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** -3.4 (Negative - indicates a short-term decline)
*   **Expected Return (%):** -574.1 (Very negative expected return compared to S&P 500)
*   **Recent Price Fluctuation:** Price decrease of -0.94 from previous close.

**Analysis:**
Despite a high MRI score suggesting a potentially safe investment, the technical indicators present a mixed picture. The RSI is neutral, indicating neither overbought nor oversold conditions. The negative divergence change over the past 20 days signals a short-term downward trend. Most alarmingly, the expected return is severely negative, indicating significant potential losses if invested long-term.

**4) Recent News & Significant Events**

*   The news headlines are mixed, some suggesting a buying opportunity ("What Makes Air Products and Chemicals (APD) a New Buy Stock") and discussing growth potential ("Is APD stock positioned for secular growth").
*   Other articles focus on investment headlines ("Opportunity in Air Products After Recent Hydrogen Investment Headlines?"), potential price movements ("Are Options Traders Betting on a Big Move in Air Products and Chemicals Stock?"), and analyst opinions ("Air Products and Chemicals (APD): Exploring Valuation After Latest Earnings Recovery").
*   One headline indicates institutional investment ("Solidarity Wealth LLC Has $7.62 Million Stock Holdings").

**Analysis:**
The news suggests a mixed sentiment. While some sources highlight potential opportunities and growth prospects, others focus on valuation concerns and potential price swings. The presence of institutional investment could be seen as a positive sign.

**4-2) Analyst Opinions**

*   **Analyst Consensus:** Buy (Mean: 1.87)
*   **Target Price:** Average: 308.86, High: 350.00, Low: 260.00
*   **Recent Rating Changes:** No specific details on changes are provided

**Analysis:**
Analysts generally have a "Buy" rating on the stock with an average target price significantly above the current price. This suggests they believe the stock is undervalued and has potential for future growth. However, without details on rating changes, it's difficult to assess the momentum of analyst sentiment.

**5) Recent Earnings Analysis**

| Date       | EPS  | Revenue    |
| ---------- | ---- | ---------- |
| 2025-07-31 | 3.2  | 3.02 B$    |
| 2025-05-01 | -7.77 | 2.92 B$    |
| 2025-02-06 | 2.77 | 2.93 B$    |
| 2024-08-01 | 3.13 | 2.99 B$    |
| 2025-07-31 | 3.13 | 2.99 B$    |

**Analysis:**
The recent earnings data is concerning. While some quarters show positive EPS, the negative EPS of -7.77 in 2025-05-01 is a red flag. Revenue has been relatively stable but not showing significant growth. It looks like there is a duplicate of 2024-08-01 to 2025-07-31 in the table.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| ------------ | --------- | ------------- |
| 2025-09-30   | $3.17B   | 32.25%        |
| 2025-06-30   | $3.02B   | 32.51%        |
| 2025-03-31   | $2.92B   | 29.57%        |
| 2024-12-31   | $2.93B   | 31.21%        |
| 2024-09-30   | $3.19B   | 33.98%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE      |
| ------------ | --------- | -------- |
| 2025-09-30   | $15.02B   | 0.03%    |
| 2025-06-30   | $15.54B   | 4.59%    |
| 2025-03-31   | $14.70B   | -11.77%   |
| 2024-12-31   | $16.69B   | 3.70%    |
| 2024-09-30   | $17.04B   | 11.45%   |

**Analysis:**
Revenue has been relatively stable with a slight increase in the most recent quarter. Profit margins have been consistent, hovering around 30-34%. However, the Return on Equity (ROE) has been volatile, with a significant negative value in 2025-03-31 and a near-zero value in the most recent quarter. This suggests issues with profitability relative to equity. The equity has also decreased during the analysis period.

**7) Comprehensive Analysis (Summary)**

Overall, the analysis paints a concerning picture for Air Products and Chemicals Inc. (APD):

*   **Underperformance:**  The stock has significantly underperformed the S&P 500, with a large negative divergence.
*   **Negative Alpha:**  The stock's risk-adjusted performance has been poor, as evidenced by negative alpha values in recent periods.
*   **Earnings Volatility:** Earnings have been inconsistent, with at least one quarter showing a very large EPS loss.
*   **ROE Concerns:** Return on Equity has been volatile and recently very low, suggesting potential issues with profitability relative to equity.
*   **Mixed News:** While some news articles highlight potential growth opportunities, others focus on valuation concerns.
*   **Analyst Optimism:** Analysts generally rate the stock as a "Buy" with a target price significantly above the current price, this differs greatly from the hybrid signal which recommends 100% cash buy.
*   **Technical Indicators:**  The RSI is neutral, but the negative divergence change and very negative expected return indicate potential for further short-term price decline.
*   **MRI Score:** The Market Risk Indicator (MRI) suggests a "High Investment Recommended", however, the technical indicators, financial performance, and negative expected returns raise significant concerns.

**Conclusion:**

While analysts are optimistic and the MRI suggests a safe investment, the underlying financial performance and technical indicators point to significant risks. The negative divergence from the S&P 500, negative alpha, volatile earnings, and low ROE warrant caution. The extremely negative expected return is a major concern.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.